Use of anti-diabetic medications that can cause hypoglycemia or other adverse events (i.e., sulfonylureas and TZDs) decreased ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Ozempic is the brand name of semaglutide, an anti-diabetic medication for those with Type 2 diabetes, for which Ozempic is approved by the Food and Drug Administration for managing.

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

The Delhi High Court on Tuesday disposed of a public interest litigation (PIL) raising alarm over the off-label and ...

These Diabetes Drugs Are Finding New Life as an Antiaging Hack Despite incomplete evidence, longevity enthusiasts are experimenting with SGLT2 inhibitors in their quest to live healthier for longer By ...

In regard to efficacy, a secondary outcome, the difference between UBX1325 and sham in mean change to week 48 in best-corrected visual acuity was 5.6 more Early Treatment of Diabetic Retinopathy ...